Cefepime exposure in prolonged or intermittent infusion in critically ill children
Preprint
- 29 July 2025
- preprint
- Published by Wiley
Abstract
Introduction : Cefepime is commonly used in critically ill children for whom there is a high between subject variability. To reach the therapeutic pharmacokinetic (PK) target in critically ill patients, beta-lactams prolonged infusion seems to be the most efficient. The aim of this study was to compare cefepime exposure between prolonged and intermittent infusions in critically ill children. Methods : This prospective observational study was conducted in two pediatric intensive care units. Children with a cefepime plasma concentration measurement were included. Steady-state free residual and plateau concentrations were estimated using Bayesian forecasting. The PK target was defined as 100% f T ≥4xMIC . Exposure was compared using the minimum inhibitory concentrations (MIC) of the pathogens identified in the patients. The probability of target attainment (PTA) was also compared using various MICs. Results : Seventy-eight antibiotic courses in 75 patients were included, divided into 19 prolonged infusions and 59 intermittent infusions. Prolonged and intermittent infusions were comparable for optimal exposure (n=10/19, 53% vs n=35/59, 59%, p=0.79). Overexposure tended to be more frequent with prolonged infusion (n=8/19, 42% vs n=16/59, 27%, p=0.26), while underexposure tended to be less common with prolonged infusion (n=1/19, 5% vs n=8/59, 14%, p=0.44). Considering the wide range of MICs, the PTA was comparable for MIC < 1 mg/L, but was significantly higher for prolonged infusion for MIC ≥ 1 mg/L (pConclusion : Prolonged infusion of cefepime provides a higher PTA when MIC is ≥ 1 mg/L compared with intermittent infusion. This result suggests the superiority of prolonged infusion for high MIC bacteria.Keywords
All Related Versions
- Version 1, 2025-07-29, Authorea
- Published version: British Journal of Clinical Pharmacology.